- Home
- IGC vs SDST Comparison
IGC vs SDST Comparison
Compare IGC & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- SDST
- Stock Information
- Founded
- IGC 2005
- SDST 2022
- Country
- IGC United States
- SDST United States
- Employees
- IGC N/A
- SDST N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- SDST Blank Checks
- Sector
- IGC Health Care
- SDST Finance
- Exchange
- IGC Nasdaq
- SDST Nasdaq
- Market Cap
- IGC 39.8M
- SDST 34.3M
- IPO Year
- IGC N/A
- SDST N/A
- Fundamental
- Price
- IGC $0.42
- SDST $4.18
- Analyst Decision
- IGC Strong Buy
- SDST Buy
- Analyst Count
- IGC 2
- SDST 2
- Target Price
- IGC $4.00
- SDST $17.00
- AVG Volume (30 Days)
- IGC 695.2K
- SDST 351.7K
- Earning Date
- IGC 11-11-2025
- SDST 11-12-2025
- Dividend Yield
- IGC N/A
- SDST N/A
- EPS Growth
- IGC N/A
- SDST N/A
- EPS
- IGC N/A
- SDST N/A
- Revenue
- IGC $1,327,000.00
- SDST N/A
- Revenue This Year
- IGC $15.26
- SDST N/A
- Revenue Next Year
- IGC $3.41
- SDST N/A
- P/E Ratio
- IGC N/A
- SDST N/A
- Revenue Growth
- IGC 24.95
- SDST N/A
- 52 Week Low
- IGC $0.25
- SDST $1.43
- 52 Week High
- IGC $0.50
- SDST $91.90
- Technical
- Relative Strength Index (RSI)
- IGC 52.73
- SDST 81.47
- Support Level
- IGC $0.39
- SDST $2.98
- Resistance Level
- IGC $0.43
- SDST $4.28
- Average True Range (ATR)
- IGC 0.02
- SDST 0.30
- MACD
- IGC -0.00
- SDST 0.03
- Stochastic Oscillator
- IGC 44.42
- SDST 85.49
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).